Network meta-analysis on efficacy and safety of different biologics for ulcerative colitis

BACKGROUND: Therapeutic options for ulcerative colitis (UC) have increased since the introduction of biologics a few decades ago. Due to the wide range of biologics available, physicians have difficulty in selecting biologics and do not know how to balance the best drug between clinical efficacy and...

Descripción completa

Detalles Bibliográficos
Autores principales: Chu, Xinqiao, Biao, Yaning, Liu, Chengjiang, Zhang, Yixin, Liu, Chenxu, Ma, Ji-zheng, Guo, Yufeng, Gu, Yaru
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557260/
https://www.ncbi.nlm.nih.gov/pubmed/37803294
http://dx.doi.org/10.1186/s12876-023-02938-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10557260/
https://www.ncbi.nlm.nih.gov/pubmed/37803294
http://dx.doi.org/10.1186/s12876-023-02938-6

Ejemplares similares